Entheon Biomedical Corp., formerly MPV Exploration Inc., is a biotechnology research and development company. The Company focuses on developing a portfolio of Dimethyltryptamine (DMT) based psychedelic therapeutic products for treating addiction and substance use disorders. It focuses on providing therapeutics for severe depression, severe Post-traumatic stress disorder (PTSD) and treatment resistant depression.